UPDATE 5-Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal
March 29, 2019 at 13:08 PM EDT
Activist hedge fund Starboard Value LP on Friday abandoned a campaign to convince Bristol-Myers Squibb Co shareholders to vote down the drugmaker's proposed $74 billion takeover of biotech Celgene Corp after the two leading proxy advisory firms backed the deal.
